Detalhe da pesquisa
1.
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability.
Cell;
187(10): 2536-2556.e30, 2024 May 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38653237
2.
Combination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recycling.
Proc Natl Acad Sci U S A;
107(30): 13252-7, 2010 Jul 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20616078
3.
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability.
bioRxiv;
2023 Oct 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37961514
4.
Direct detection of OXA-48-like carbapenemase variants with and without co-expression of an extended-spectrum ß-lactamase from bacterial cell lysates using mass spectrometry.
J Mass Spectrom Adv Clin Lab;
20: 25-34, 2021 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34820668
5.
Rapid MRSA detection via tandem mass spectrometry of the intact 80 kDa PBP2a resistance protein.
Sci Rep;
11(1): 18309, 2021 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34526615
6.
Direct detection of intact Klebsiella pneumoniae carbapenemase variants from cell lysates: Identification, characterization and clinical implications.
Clin Mass Spectrom;
17: 12-21, 2020 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34820520
7.
Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms.
Carcinogenesis;
29(11): 2227-35, 2008 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18725385
8.
Fibulins 3 and 5 antagonize tumor angiogenesis in vivo.
Cancer Res;
66(5): 2621-9, 2006 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16510581
9.
SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.
Mol Biol Cell;
14(10): 3977-88, 2003 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-14517312
10.
The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.
Breast Cancer Res;
7(5): R844-53, 2005.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16168131
11.
Epidermal growth factor receptor downregulation by small heterodimeric binding proteins.
Protein Eng Des Sel;
25(2): 47-57, 2012 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22160867
12.
Transforming growth factor-ß and the hallmarks of cancer.
Cell Signal;
23(6): 951-62, 2011 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20940046
13.
X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progression.
J Biol Chem;
284(32): 21209-17, 2009 Aug 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19531477
14.
Altered TAB1:I kappaB kinase interaction promotes transforming growth factor beta-mediated nuclear factor-kappaB activation during breast cancer progression.
Cancer Res;
68(5): 1462-70, 2008 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18316610
15.
Role of transforming growth factor-beta in cancer progression.
Future Oncol;
2(6): 743-63, 2006 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17155901
16.
TGF-beta in cancer and other diseases.
Future Oncol;
2(2): 185-9, 2006 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16563087